Teva's Nexium Deal With AstraZeneca May Erode Ranbaxy's 2014 Marketing Exclusivity
This article was originally published in The Pink Sheet Daily
Executive Summary
While analysts from two foreign institutions said Ranbaxy's exclusivity will erode if Teva also launches generic esomeprazole in May 2014, an Indian analyst maintained Ranbaxy's position appears solid.